Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC or Sodium Bicarbonate for CIN Prevention in CRF Patients
NCT00501475Phase 4Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acetylcysteine, sodium bicarbonate in contrast-induced nephropathy (CIN), sponsored by Seoul National University Hospital. Status: unknown.
02
Drugs
acetylcysteinesodium bicarbonate
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT00501475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00501475.